CooperVision produces hand sanitizer at manufacturing sites

Article

Initiative helps eye care and local communities address COVID-19

In response to the ongoing COVID-19 pandemic, CooperVision converted two of its manufacturing facilities into hand sanitizer production sites. One manufacturing location is in Hampshire, United Kingdom, the other is in Juana Diaz, Puerto Rico.

Benefits are two-fold: a portion of the sanitizer that is being produced stocks internal supplies for employee hygiene needs. This consistent, internal supply ensures commercial stocks are freed for consumer use elsewhere, according to the company. Additional reserves are being donated to community organizations and customers.

Related: CooperVision reveals virtual exhibit booth

Before conversion, the UK and Juana Diaz sites were manufacturing a range of contact lenses, including Biofinity and MyDay. Laboratory and operating procedure re-designs were issued in order to meet material handling retirements. The company was able to produce bottles of hand sanitizer in volume—safely, efficiently and in line with World Health Organization (WHO) guidelines—within 3 weeks.


Community recipients include areas of the National Health Service, schools, community facilities, care homes, and charities. In the US, the company has distributed complimentary bottles to customers as well.

Related: Allergan receives FDA complete response letter for wet AMD therapy

Recent Videos
David Geffen, OD, FAAO, gave a poster presentation titled "Revolutionizing Comfort: Unveiling the Potential of Perfluorohexyloctane Eyedrops for Contact Lens Wearers" at this year's Academy meeting.
Jessica Steen, OD, FAAO, Dipl-ABO, discussed ophthalmic considerations for patients undergoing treatment with antibody drug conjugates for gynecologic cancers at this year's conference.
A. Paul Chous, MA, OD, FAAO, details a presentation on this year's updates on diabetes given at this year's Academy meeting
Sherrol Reynolds, OD, FAAO, said that multimodel imaging has been a game changer in assessing the choroidal function and structural changes in various disease conditions.
Susan Gromacki, OD, FAAO, FSLS, provides key takeaways from this year's American Academy of Optometry symposium genetics and the cornea.
Roya Attar gives an overview of her presentation, "Decoding the Retina: The Value of Genetic Testing In Inherited Disorders," presented with Mohammad Rafieetary, OD, FAAO, FORS, ABO, ABCMO.
Ian Ben Gaddie, OD, FAAO, outlines key findings from a recent study evaluating lotilaner in patients with Demodex blepharitis and meibomian gland dysfunction.
Clark Chang, OD, MSA, MSc, FAAO, discussed the complexities of diagnosing keratoconus in his Rapid Fire presentation given at the American Academy of Optometry 2024 meeting.
Mohammad Rafieetary, OD, FAAO, FORS, Dipl ABO, ABCMO, details the ease of genetic testing when diagnosing patients or reassessing a patient's diagnosis.
Gromacki, OD, FAAO, FSLS, emphasizes that corneal GP lenses remain an important part of a contact lens specialist's armamentarium
© 2024 MJH Life Sciences

All rights reserved.